Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

A Dose Range-Finding Study to Assess the Efficacy and Safety of Multiple Dose Levels of AZD8630 in Adults With Uncontrolled Asthma at Risk of Exacerbations

ClinicalTrials.gov ID: NCT06529419

Public ClinicalTrials.gov record NCT06529419. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 17, 2026, 9:15 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2b, Randomised, Double-Blind, Placebo-Controlled Dose Range-Finding Study to Assess Efficacy and Safety of Multiple Dose Levels of Inhaled AZD8630 Given Once Daily for 12 Weeks in Adults With Uncontrolled Asthma at Risk of Exacerbations (LEVANTE)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

A dose range-finding study to assess the efficacy and safety of multiple dose levels of AZD8630 administered via a dry powder inhaler in adults with uncontrolled asthma at risk of exacerbations, receiving medium -to -high dose inhaled corticosteroid (ICS)/long-acting β2-agonist (LABA).

Study identification

NCT ID
NCT06529419
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
AstraZeneca
Industry
Enrollment
537 participants

Conditions and interventions

Conditions

Interventions

Drug · Device

Eligibility (public fields only)

Age range
18 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 30, 2024 (Actual)
Primary completion
Feb 4, 2026 (Actual)
Completion
Feb 4, 2026 (Actual)
Last update posted
Mar 2, 2026

2024 – 2026

United States locations

U.S. sites
45
U.S. states
22
U.S. cities
44
Facility City State ZIP Site status
Research Site Mesa Arizona 85213 —
Research Site Huntington Beach California 92647 —
Research Site La Mesa California 91942 —
Research Site Laguna Niguel California 92677 —
Research Site Lancaster California 93534 —
Research Site Long Beach California 90815 —
Research Site San Jose California 95117 —
Research Site New Haven Connecticut 06510 —
Research Site DeBary Florida 32713 —
Research Site Jacksonville Florida 32216 —
Research Site Jensen Beach Florida 34957 —
Research Site Largo Florida 33777 —
Research Site Miami Florida 33135 —
Research Site Miami Lakes Florida 33014 —
Research Site Tampa Florida 33607 —
Research Site Lilburn Georgia 30047 —
Research Site Savannah Georgia 31406 —
Research Site Chicago Illinois 60616 —
Research Site Winfield Illinois 60190 —
Research Site Ames Iowa 50010 —
Research Site Kansas City Kansas 66160 —
Research Site Baltimore Maryland 21237 —
Research Site Methuen Massachusetts 01844 —
Research Site Ann Arbor Michigan 48109 —
Research Site Detroit Michigan 48202 —
Research Site Las Vegas Nevada 89102 —
Research Site Las Vegas Nevada 89119 —
Research Site Riverdale New Jersey 07457 —
Research Site Middletown New York 10941 —
Research Site Greenville North Carolina 27834 —
Research Site Winston-Salem North Carolina 27104 —
Research Site Beavercreek Ohio 45431 —
Research Site Lima Ohio 45801 —
Research Site Oklahoma City Oklahoma 73120 —
Research Site Horsham Pennsylvania 19044 —
Research Site Austin Texas 78704 —
Research Site McKinney Texas 75069 —
Research Site Mesquite Texas 75149 —
Research Site Pearland Texas 77584 —
Research Site San Antonio Texas 78215 —
Research Site American Fork Utah 84003 —
Research Site Roy Utah 84067 —
Research Site Salt Lake City Utah 84124 —
Research Site Hampton Virginia 23666 —
Research Site Milwaukee Wisconsin 53228 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 151 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06529419, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 2, 2026 · Synced Oct 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT06529419 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →